Expansion Momentum Prime IV continues rapid nationwide growth with over 140 locations and multiple new openings in 2026, presenting ongoing sales opportunities to partner with franchisees, real estate developers, and local health providers seeking IV therapy and NAD+ service expansion.

Recognition & Credibility National awards and high rankings (Entrepreneur Franchise 500 Best of the Best, Inc. 5000, top IV Therapy brand) create a strong credibility signal that can ease prospecting with potential franchisees, landlords, and suppliers seeking a proven, award-winning partner.

Financial Capacity Significant revenue scale and recent senior secured financing with Lafayette Square indicate healthy capital access and growth runway, suggesting opportunities to discuss financing partnerships, equipment leasing, and service-line investments (IV, NAD+, rapid weight loss) with clinics and corporate wellness programs.

Service Diversification Broad portfolio including IV therapy, micronutrient injections, NAD+ treatments, and weight loss solutions enables cross-sell and upsell to existing wellness clients, corporate wellness programs, and medical partners seeking comprehensive, personalized wellness offerings.

Data & Tech Enablement Adopted tech stack (Google Analytics, Facebook Pixel, analytics tools) offers a foundation for data-driven marketing collaborations, patient acquisition strategies, and digital marketing partnerships aimed at scaling new locations and improving retention.